For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Florida will get $3 million as part of a nationwide settlement over allegations a drug manufacturer gave kickbacks to doctors ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

An HIV prevention drug will be made available at a new, low cost in 120 low- and middle-income countries starting in 2027, according to an announcement yesterday. The move is being called a “once-in-a ...

An experimental gene therapy from Uniqure slowed the progression of Huntington’s disease by 75% after three years ...

A game-changing HIV prevention drug is set to become vastly more affordable in over 100 low- and middle-income countries, a move that could bring the world closer to ending the HIV/AIDS epidemic.